US Patent Issued to The University of Tokyo, Yamaguchi University on April 7 for "Therapeutic and prophylactic agent for glioma, brain tumor malignancy marker, brain tumor prognostic marker, method for determining malignancy and prognosis of brain tumor and antibody inhibiting tumor proliferation" (Japanese Inventors)

ALEXANDRIA, Va., April 7 -- United States Patent no. 12,594,294, issued on April 7, was assigned to The University of Tokyo (Tokyo) and Yamaguchi University (Yamaguchi, Japan).

"Therapeutic and prophylactic agent for glioma, brain tumor malignancy marker, brain tumor prognostic marker, method for determining malignancy and prognosis of brain tumor and antibody inhibiting tumor proliferation" was invented by Kohei Miyazono (Tokyo), Ryo Tanabe (Tokyo), Masato Morikawa (Tokyo), Carl-Henrik Heldin (Tokyo), Bengt Westermark (Tokyo) and Koji Tamada (Yamaguchi, Japan).

According to the abstract* released by the U.S. Patent & Trademark Office: "A novel agent is for treating or preventing a glioma. A marker for malignancy of a brain tumor and a pr...